| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |